2,5-diketopiperazines as potent and selective oxytocin antagonists - 1: identification, stereochemistry and initial SAR

被引:59
|
作者
Wyatt, PG
Allen, MJ
Borthwick, AD
Davies, DE
Exall, AM
Hatley, RJD
Irving, WR
Livermore, DG
Miller, ND
Nerozzi, F
Sollis, SL
Szardenings, AK
机构
[1] GlaxoSmithKline Res & Dev Ltd, Dept Med Chem, CVU UK, Med Res Ctr, Stevenage SG1 2NY, Herts, England
[2] GlaxoSmithKline Res & Dev Ltd, ADCP Harlow Res 2, Harlow CM19 5AW, Essex, England
[3] Affymax Res Inst, Santa Clara, CA 95051 USA
关键词
oxytocin; oxytocin receptor; preterm birth; antagonists; unencoded libraries; 2,5-diketopiperidines; Ugi reaction; screening; pooled libraries; solid phase; structure-activity relationships;
D O I
10.1016/j.bmcl.2005.03.045
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This paper covers efforts to discover orally active potent and selective oxytocin antagonists. Screening pooled libraries identified a novel series of 2,5-diketopiperazine derivatives with antagonist activity at the human oxytocin receptor. We report the initial structure-activity relationship investigations and the determination of the stereochemistry of the most potent compounds. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2579 / 2582
页数:4
相关论文
共 50 条
  • [21] Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists:: 1H-Pyrimidin-2-one derivatives
    Geneste, H
    Backfisch, G
    Braje, W
    Delzer, J
    Haupt, A
    Hutchins, CW
    King, LL
    Kling, A
    Teschendorf, HR
    Unger, L
    Wernet, W
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) : 490 - 494
  • [22] Identification and optimization of substituted 5-aminopyrazoles as potent and selective adenosine A1 receptor antagonists
    Griebenow, Nils
    Baerfacker, Lars
    Meier, Heinrich
    Schneider, Dirk
    Teusch, Nicole
    Lustig, Klemens
    Kast, Raimund
    Kolkhof, Peter
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) : 5891 - 5894
  • [23] Synthesis and SAR of novel imidazoles as potent and selective cannabinoid CB2 receptor antagonists with high binding efficiencies
    Lange, Jos H. M.
    van der Neut, Martina A. W.
    Wals, Henri C.
    Kuil, Gijs D.
    Borst, Alice J. M.
    Mulder, Arie
    den Hartog, Arnold P.
    Zilaout, Hicham
    Goutier, Wouter
    van Stuivenberg, Herman H.
    van Vliet, Bernard J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1084 - 1089
  • [24] Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists:: Variations on the 1H-pyrimidin-2-one theme
    Geneste, H
    Amberg, W
    Backfisch, G
    Beyerbach, A
    Braje, WM
    Delzer, E
    Haupt, A
    Hutchins, CW
    King, LL
    Sauer, DR
    Unger, L
    Wernet, W
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) : 1934 - 1937
  • [25] Site selective synthesis of cytotoxic 1,3,6-trisubstituted 3,6-diunsaturated (3Z,6Z)-2,5-diketopiperazines via a one-pot multicomponent method
    Liao, Sheng-Rong
    Du, Li-Juan
    Qin, Xiao-Chu
    Xu, Liang
    Wang, Jun-Feng
    Zhou, Xue-Feng
    Tu, Zheng-Chao
    Li, Juan
    Liu, Yong-Hong
    TETRAHEDRON, 2016, 72 (08) : 1051 - 1057
  • [26] Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists
    Hipskind, PA
    Lobb, KL
    Nixon, JA
    Britton, TC
    Bruns, RF
    Catlow, J
    DieckmanMcGinty, DK
    Gackenheimer, SL
    Gitter, BD
    Iyengar, S
    Schober, DA
    Simmons, RMA
    Swanson, S
    Zarrinmayeh, H
    Zimmerman, DM
    Gehlert, DR
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (23) : 3712 - 3714
  • [27] Design, synthesis and SAR analysis of novel potent and selective small molecule antagonists of NPBWR1 (GPR7)
    Urbano, Mariangela
    Guerrero, Miguel
    Zhao, Jian
    Velaparthi, Subash
    Saldanha, S. Adrian
    Chase, Peter
    Wang, Zhiwei
    Civelli, Olivier
    Hodder, Peter
    Schaeffer, Marie-Therese
    Brown, Steven
    Rosen, Hugh
    Roberts, Edward
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (23) : 7135 - 7141
  • [28] Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor1 (CRF1) receptor antagonists
    Huang, CQ
    Grigoriadis, DE
    Liu, ZY
    McCarthy, JR
    Ramphal, J
    Webb, T
    Whitten, JP
    Xie, MY
    Chen, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2083 - 2086
  • [29] Noncompetitive nature of oxytocin antagonists with general structure Mpa1XXX2Sar7Arg8
    Havass, J
    Bakos, K
    Márki, A
    Gáspár, R
    Gera, L
    Stewart, JM
    Fülöp, F
    Tóth, GK
    Zupkó, I
    Falkay, G
    PEPTIDES, 2002, 23 (08) : 1419 - 1425
  • [30] Identification of fused bicyclic heterocycles as potent and selective 5-HT2A receptor antagonists for the treatment of insomnia
    Xiong, Yifeng
    Ullman, Brett
    Choi, Jin-Sun Karoline
    Cherrier, Martin
    Strah-Pleynet, Sonja
    Decaire, Marc
    Feichtinger, Konrad
    Frazer, John M.
    Yoon, Woo H.
    Whelan, Kevin
    Sanabria, Erin K.
    Grottick, Andrew J.
    Al-Shamma, Hussien
    Semple, Graeme
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (05) : 1870 - 1873